CNSX:MMENMedmen Enterprises Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Medmen Enterprises Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range$0.26MA: $0.34▼$0.5052-Week Range N/AVolume770,154 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileChartCompetitorsInsider TradesHeadlines MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, and distributes, and retails recreational and medicinal cannabis. As of November 1, 2018, it had licenses for 69 retail stores; and 17 cultivation and production facilities across 12 states. The company is headquartered in Culver City, California.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Medmen Enterprises. Previous Next 3.2 Community Rank Outperform VotesMedmen Enterprises has received 33 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMedmen Enterprises has received 19 “underperform” votes. (Add your “underperform” vote.)Community SentimentMedmen Enterprises has received 63.46% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Medmen Enterprises and other stocks. Vote “Outperform” if you believe MMEN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MMEN will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMedmen Enterprises does not currently pay a dividend.Dividend GrowthMedmen Enterprises does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Medmen Enterprises insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $224,495.00 in company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.64 out of 5 stars Industry, Sector and Symbol Stock Exchange CNSX Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolCNSX:MMEN Previous Symbol CUSIPN/A CIKN/A Webwww.medmen.com Phone424-341-4969Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable 30 days | 90 days | 365 days | Advanced Chart Receive MMEN News and Ratings via Email Sign-up to receive the latest news and ratings for MMEN and its competitors with MarketBeat's FREE daily newsletter. Medmen Enterprises (CNSX:MMEN) Frequently Asked Questions Has Medmen Enterprises been receiving favorable news coverage? News articles about MMEN stock have trended somewhat negative this week, InfoTrie Sentiment reports. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Medmen Enterprises earned a news impact score of -1.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Medmen Enterprises. Who are some of Medmen Enterprises' key competitors? Some companies that are related to Medmen Enterprises include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF) and CLS Holdings USA (CLSH). View all competitors. What other stocks do shareholders of Medmen Enterprises own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medmen Enterprises investors own include Aurora Cannabis (ACB), Medmen Enterprises (MMNFF), Aurora Cannabis (ACB), Green Organic Dutchman (TGOD), Canopy Growth (CGC), CannTrust (CTST), OrganiGram (OGI), Canopy Growth (WEED), NIO (NIO) and Cronos Group (CRON). Who are Medmen Enterprises' key executives? Medmen Enterprises' management team includes the following people: Mr. Adam Bierman, Co-Founder, CEO & Director (Age 38)Mr. Andrew Modlin, Co-Founder, Pres & Director (Age 32)Mr. Michael W. Kramer, Chief Financial Officer (Age 55)Mr. James Miller, VP of Accounting (Age 59)Mr. Ryan Lissack, Chief Technology Officer What is Medmen Enterprises' stock symbol? Medmen Enterprises trades on the CNSX under the ticker symbol "MMEN." How do I buy shares of Medmen Enterprises? Shares of MMEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Medmen Enterprises' official website? The official website for Medmen Enterprises is www.medmen.com. How can I contact Medmen Enterprises? The company can be reached via phone at 424-341-4969. This page was last updated on 8/14/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
